Voloridge Investment Management
RDY icon

Voloridge Investment Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Voloridge Investment Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15,432
Closed -$204K – 1330
2025
Q1 		$204K Buy
+15,432
New +$213K ﹤0.01% 1141
2023
Q4 		– Sell
-235,265
Closed -$3.15M – 1418
2023
Q3 		$3.15M Sell
235,265
-60,500
-20% -$819K 0.02% 794
2023
Q2 		$3.73M Sell
295,765
-119,165
-29% -$1.39M 0.02% 775
2023
Q1 		$4.72M Sell
414,930
-5,630
-1% -$60.8K 0.02% 687
2022
Q4 		$4.35M Buy
420,560
+306,050
+267% +$3.3M 0.02% 690
2022
Q3 		$1.2M Buy
114,510
+53,515
+88% +$570K 0.01% 1111
2022
Q2 		$676K Buy
+60,995
New +$663K ﹤0.01% 1268
2020
Q4 		– Sell
-109,015
Closed -$1.52M – 1521
2020
Q3 		$1.52M Sell
109,015
-119,980
-52% -$1.43M 0.01% 809
2020
Q2 		$2.43M Buy
+228,995
New +$2.33M 0.03% 552

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Voloridge Investment Management's RDY Position: Q2 2025 in Review

Voloridge Investment Management sold out of Dr. Reddy's Laboratories (RDY) in Q2 2025, closing a stake of 15,432 shares — an estimated $204K sold.

Voloridge Investment Management first reported a position in RDY in Q2 2020 and held it in 9 quarters. The position peaked at $4.72M in Q1 2023. 243 funds tracked by Wall St. Rank hold RDY as of Q2 2025.

  • Voloridge Investment Management reported no remaining Dr. Reddy's Laboratories position as of Q2 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 15,432 Dr. Reddy's Laboratories shares in Q2 2025, an estimated $204K.
  • Voloridge Investment Management first reported a position in Dr. Reddy's Laboratories in Q2 2020 and held it in 9 quarters.
  • Voloridge Investment Management's Dr. Reddy's Laboratories position peaked at $4.72M in Q1 2023.
  • 243 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2025.

Based on Voloridge Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.